Prevalence and Clinicopathologic features of different HER2 level in Chinese breast cancer patients

Trial Identifier:	D9673R00011
Sponsor:	AstraZeneca
NCTID::	NCT05203458
Start Date:	February 2022
Primary Completion Date:	May 2023
Study Completion Date:	May 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	Guangzhou, China
China	Jinan, China
China	Shenyang, China
China	Wuhan, China
China	Xian, China
China	Zhengzhou, China
China, Shanhai	Shanghai, Shanhai, China

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.